by Uniseed01 | Jan 31, 2023 | Latest News
— ENA Respiratory and COPD Foundation survey confirms patients are overwhelmingly positive about taking an immune-modulating nasal spray to reduce lung disease exacerbations– — Survey was conducted through COPD360Net®, an innovative...
by Uniseed01 | Jan 23, 2023 | Latest News
23 January 2023 – Uniseed investee Ferronova announced today it has secured a further A$11 million to progress the company’s nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal...
by Uniseed01 | Jan 10, 2023 | Latest News
— Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats Melbourne, Australia, 9th January 2023 – Clinical-stage pharmaceutical company ENA Respiratory has been awarded a $4.38 million USD agreement...
by Uniseed01 | Nov 9, 2022 | Latest News
Research presented today by University of Michigan Medical School highlights FT011’s ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data The research demonstrated that...
by Uniseed01 | Nov 3, 2022 | Latest News
Melbourne, 3 November 2022 – Uniseed has led a $1.5M investment round in the Australian microscopy products company Tiny Bright Things (TBT) to transform the way researchers and manufacturers see and measure tiny or transparent objects....
by Uniseed01 | Oct 11, 2022 | Latest News
Brisbane, 11 October 2022 – Uniseed has committed $3M to an investment in Australian quantum technology company Analog Quantum Circuits (AQC) to fund the development of key components required for the scale up of quantum computing. Uniseed led the seed...
Recent Comments